Prescriber Schedule Authority Management

The contract requires the validation and management of prescriber authority levels for controlled substances under Medicare Part D, ensuring strict adherence to DEA scheduling classifications and Prescription Drug Plan (PDP) requirements. This involves accurately verifying the legal scope of practice for prescribers, monitoring changes in their controlled substance prescribing privileges, and maintaining up-to-date systems that align with federal and state regulatory frameworks. The work demands precise data handling, continuous compliance auditing, and seamless integration with existing Medicare Part D infrastructure to prevent unauthorized access or prescribing of controlled substances. The contract is classified as a subcontract under NAICS code 518210 and is issued by the Health and Human Services Commission in Texas. Responses are due by August 17, 2026, at 4:30 PM, with the solicitation posted on August 3, 2026. While no set-aside provisions or specific point of contact details are provided, the place of performance and organizational details remain unspecified, suggesting the work may be performed remotely or across multiple locations as permitted by the terms. All work must be executed in full alignment with federal regulations governing controlled substance prescribing and Medicare Part D administrative protocols.